Juan M. Bayo

Pilar, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Context matters for SMYD2 in liver disease: from hepatoprotection to tumour immune escape.

Context matters for SMYD2 in liver disease: from hepatoprotection to tumour immune escape.

Journal: Gut

Published: May 24, 2026

Unveiling the role of age in MASLD development and biological process activation: Implications for translational research.

Unveiling the role of age in MASLD development and biological process activation: Implications for translational research.

Journal: Journal of physiology and biochemistry

Published: May 14, 2026

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Journal: Molecular therapy. Oncology

Published: January 20, 2026

Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma.

Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma.

Journal: Frontiers in cell and developmental biology

Published: December 11, 2025

4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer.

4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer.

Journal: International journal of molecular sciences

Published: September 12, 2025

Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications.

Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications.

Journal: Gut

Published: July 18, 2025

RAC1 as a novel therapeutic target for acute liver failure.

RAC1 as a novel therapeutic target for acute liver failure.

Journal: JHEP reports : innovation in hepatology

Published: January 28, 2025

Epigenetic mechanisms involved in hepatocellular carcinoma development and progression.

Epigenetic mechanisms involved in hepatocellular carcinoma development and progression.

Journal: eGastroenterology

Published: January 13, 2025

The influence of socio-economic status on the fulfilment of Saint-Gallen recommendations for early-stage breast cancer.

The influence of socio-economic status on the fulfilment of Saint-Gallen recommendations for early-stage breast cancer.

Journal: Scientific reports

Published: July 18, 2024

Targeting hyaluronan metabolism-related molecules associated with resistant tumor-initiating cells potentiates chemotherapy efficacy in lung cancer.

Targeting hyaluronan metabolism-related molecules associated with resistant tumor-initiating cells potentiates chemotherapy efficacy in lung cancer.

Journal: Scientific reports

Published: May 10, 2024

Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.

Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.

Journal: Stem cell research & therapy

Published: December 29, 2023

Osteosarcoma cells exhibit functional interactions with stromal cells, fostering a lung microenvironment conducive to the establishment of metastatic tumor cells.

Osteosarcoma cells exhibit functional interactions with stromal cells, fostering a lung microenvironment conducive to the establishment of metastatic tumor cells.

Journal: Molecular biology reports

Published: November 07, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026